Skip to main content
Veterinary Medicines

Dermamycin-Augencreme

Authorised
  • VITAMIN A CONCENTRATE (OILY FORM), SYNTHETIC
  • Hydrocortisone acetate
  • NEOMYCIN SULFATE
  • Lidocaine hydrochloride monohydrate

Product identification

Medicine name:
Dermamycin-Augencreme
Active substance:
  • VITAMIN A CONCENTRATE (OILY FORM), SYNTHETIC
  • Hydrocortisone acetate
  • NEOMYCIN SULFATE
  • Lidocaine hydrochloride monohydrate
Target species:
  • Dog
  • Cat
Route of administration:
  • Ocular use

Product details

Active substance and strength:
  • VITAMIN A CONCENTRATE (OILY FORM), SYNTHETIC
    2.94
    milligram(s)
    /
    1.00
    gram(s)
  • Hydrocortisone acetate
    5.00
    milligram(s)
    /
    1.00
    gram(s)
  • NEOMYCIN SULFATE
    5.00
    milligram(s)
    /
    1.00
    gram(s)
  • Lidocaine hydrochloride monohydrate
    10.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Eye cream
Withdrawal period by route of administration:
  • Ocular use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QS01AA20
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Almapharm GmbH & Co. KG
Marketing authorisation date:
Manufacturing sites for batch release:
  • Almapharm GmbH & Co. KG
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 6336699.00.00
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 24/01/2024

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 24/01/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."